The Senate health committee looks into its first subpoena in 40 years
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Category: Medicine
STAT+: Hospitals offer their custom-built tech for sale in search of new revenue streams
Hospitals aren’t usually in the business of selling technology tools. But that’s changing thanks to…
Opinion: Clogged arteries: the unseen cost of road-blocking protests
Recent events in Israel and Gaza have sparked a wave of protests, with some activists…
Opinion: STAT+: The necessary roughness of 2023 has set up a very promising 2024 for biotech jobs
What a week — this year’s might have been the busiest JPM I’ve ever had….
STAT+: The FDA’s diagnostics chief, who led through Covid, has retired
Timothy Stenzel, the federal regulator who led the Food and Drug Administration’s diagnostics division during…
.jpg)
STAT+: Klobuchar urges drugmakers to remove patents FTC calls improper and inaccurate
Amid a push to crack down on patent abuse by the pharmaceutical industry, a key…
Biotech layoffs, slumping stocks, and a 2024 preview
Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going…
Will Congress get any health policy done this year?
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Microsoft to embed AI tool for clinical documentation in Epic’s health records software
Microsoft on Thursday said it will launch its artificial intelligence tool for automating clinical documentation…
STAT+: Humana slashes profit predictions amid soaring Medicare Advantage costs
Humana’s Medicare Advantage enrollees got care in the hospital and physician clinics way more often…
STAT+: Bernie Sanders proposes subpoenas of CEOs of J&J, Merck on drug prices
WASHINGTON — Senate health committee chair Bernie Sanders has taken a step toward subpoenaing the…
Could long Covid’s signs of immune dysregulation in the blood lead to a diagnostic test?
Long Covid has long eluded scientists looking for its cause. Not knowing what triggers its…
STAT+: Pipelines from high school to health care jobs to be created by new Bloomberg Philanthropies initiative
The Edward M. Kennedy Academy for Health Careers will be revamped to create a guaranteed…
STAT+: CRISPR-edited pig liver from eGenesis passes first test in brain-dead human, researchers say
For three days in December, an ICU room at the Hospital of the University of…
STAT+: Apple removes pulse oximeter feature in Watches to comply with ban
Apple will remove the blood oxygen measurement feature from its Apple Watches, the company announced…
The XBI comedown after JPM
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about drug price hikes, Bayer strategic moves, and more
Rise and shine, everyone, another busy day is on the way. Sadly, gray skies are…
STAT+: How digital therapeutics companies are improvising when insurance coverage isn’t guaranteed
For years, the playbook for many companies that wanted to market digital therapeutics was stupid…
Pumping breastmilk in bathrooms is a common, albeit unspoken, practice at health care conferences
Even though Erin Booth was not thrilled about having to travel to Philadelphia for a…
Opinion: A new HHS rule rules takes a far too narrow approach to health care data interoperability
In 2016, the 21st Century Cures Act required that the U.S. make progress toward interoperability,…
Amid a dire nationwide therapist shortage, could lay counselors help close the gap?
One morning last May, 10 students and two instructors from across California gathered on Zoom…
STAT+: Congress’ negotiations over doc pay, health centers fell apart ahead of spending extension
WASHINGTON — Negotiations to add extra health care policies to Congress’ stopgap funding bill fell…
STAT+: Testosterone didn’t lower fracture risk in a surprising new study. Researchers have theories about why
Testosterone is essential for bone health in men. It helps maintain bone density and improve…
STAT+: Biden changes will force health insurers to speed up and get more specific if they want to deny care
The Biden administration moved Wednesday to force insurance companies to give specific reasons for denying…
STAT+: Copay coupons for some drugs must count toward deductibles, after Biden court move
WASHINGTON — Insurers will have to count drug copay coupons toward deductibles and patient spending…
General Catalyst to buy Ohio-based health system Summa Health
Venture capital firm General Catalyst has agreed to acquire Ohio-based nonprofit health system Summa Health…
The big any-day-now biotech news we’re keeping an eye on
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about a CRISPR approval, selling meds directly to patients, and more
Rise and shine, everyone. The middle of the week is upon us. Have heart, though….
STAT+: FDA clears AI skin cancer detector for primary care doctors to use
The Food and Drug Administration cleared an AI-powered device for detecting skin cancer on Wednesday,…
STAT+: More patients are getting their meds online. Big Pharma wants in on the action
Since the pandemic, patients have become increasingly comfortable with getting their medications online. Direct-to-consumer telehealth…
A new, non-invasive test could help predict the quality of embryo used for IVF
Researchers from the University of California San Diego School of Medicine say a new method…
STAT+: Hair loss is one of the most hated chemotherapy side effects. A new biotech hopes to prevent it
The chemotherapy Christine Ko was prescribed for her breast cancer is pretty much a guarantee…
STAT+: At health care’s biggest investor conference, AI’s high hopes collided with skepticism
You didn’t need machine learning to make one prediction about the year’s biggest conference for…
Opinion: The decline and fall of elite multispecialty medical groups
The failure of Geisinger Health System, which lost $842 million in 2022 and disappeared into…
STAT+: Dewpoint Therapeutics cuts 15% of staff, acknowledges Merck, Pfizer broke off partnerships over buzzy science
Dewpoint Therapeutics, the buzziest startup trying to tackle a new field of biology called biomolecular…
STAT+: FDA expands approval of CRISPR-based medicine to treat beta thalassemia
The Food and Drug Administration on Tuesday approved a CRISPR-based medicine to treat beta thalassemia,…
STAT+: Survey: Confusion over key requirements means clinical trials aren’t registered and results aren’t reported
More than half of those responsible for registering clinical trials and reporting results fail to…
The state of Medicare Advantage, in one chart
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
Health care negotiations on Capitol Hill are clear as mud
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Pharmalittle: We’re reading about Wegovy shipments, the NIH director’s plans, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite —…
The four biotech stories you need to read this morning
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: The new NIH director is walking a tightrope on Biden’s drug pricing vision
WASHINGTON — President Biden has promised to require fair prices from drugmakers that use federally…
Opinion: Cord blood banking sounds like a great idea — until you realize what it costs babies
If her social media accounts are any indication, model, cookbook author, television personality, and entrepreneur…
The WHO and drug regulators want to reformulate the flu vaccine. It’s easier said than done
Last fall, the World Health Organization and some national drug regulators urged influenza vaccine manufacturers…
STAT+: Many doctors are in the dark about how FDA approves devices and drugs, survey finds
In her final presentation for health policy class at the University of Chicago, first-year medical…
STAT+: Could private equity be the future of private practice? A new lobbying group thinks so
Private equity gets a bad rap in health care. But some doctors see that kind…
Opinion: BMI as a barrier to orthopedic surgery doesn’t make sense for patient health
I am getting bent out of shape over surgeons telling patients they cannot get a…
STAT+: For-profit biomedical institute, backed by billionaires, launches in Cambridge to speed drug discovery
A team of high-powered scientists and billionaire investors said Friday that they’re launching a biomedical…
Opinion: What STAT readers think about JPM’s locked lactation room, covering weight loss drugs, and more
STAT now publishes selected Letters to the Editor received in response to First Opinion essays…
Novartis reportedly decides to pass on Cytokinetics
Want to stay on top of the science and politics driving biotech today? Sign up to get…